Intuitive Surgical reports earnings with eyes on a 17.1% revenue increase to $2.35 billion. Last quarter, the company surpassed revenue forecasts by 3.1%, hitting $2.25 billion. Despite a mixed ...

Q2 2025 Earnings Call Transcript July 17, 2025 Abbott Laboratories reports earnings inline with expectations. Reported EPS is ...

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

The firm saw growth in its core laboratory segment but declines in molecular, point of care, and rapid diagnostics.

Abbott Laboratories ( NYSE: ABT) was upgraded to Buy from Hold at Jefferies following its Q2 results and revised guidance, as analysts view the market reaction as “overly punitive” and see an ...

Abbott Labs reported a mixed bag of Q2 2025 earnings, showing impressive growth in some areas and facing headwinds in others. Sales grew by almost 7%, and adjusted EPS saw an 11% increase. Medical ...

Abbott Laboratories (ABT) reports robust earnings growth and margin expansion, driven by medical devices, despite headwinds ...

Abbott Laboratories CEO Robert Ford unpacked his company’s latest quarterly report in a Thursday interview with CNBC’s Jim ...

Abbott second-quarter results came in ahead of the consensus forecast, with its Medical Device business growing 13.4%.

Live Updates Live Coverage Updates appear automatically as they are published. Still no earnings at 7:05 a.m. ET 7:04 am by ...

Q2 2025 Results Conference Call July 17, 2025 9:00 AM ETCompany ParticipantsMichael Comilla - Vice President of ...